INSIGHTS ON QUALITY CONTROL
-
![GettyImages-1371925389-lab-scientist-collaboration-computer-clipboard]( "How Do You Navigate GxP Compliance?")
How Do You Navigate GxP Compliance?Heightened FDA scrutiny demands a shift from fragmented data to unified digital systems. Learn how to automate QA tasks, secure data integrity, and maintain a constant state of inspection readiness.
-
![GettyImages-1690936576-inspection-in-factory]( "Physical Contamination Detection")
Physical Contamination DetectionLearn how physical contaminants enter production lines and how detection systems like metal detection and X-ray inspection help prevent defects and recalls to strengthen quality control.
-
![Medical research, technology, innovation, AI-GettyImages-2226144959]( "An Overview Of 2026 Life Sciences Industry Trends")
An Overview Of 2026 Life Sciences Industry TrendsExplore the paradigm shift reshaping life sciences. Learn how connecting data streams across the product lifecycle drives predictive compliance and operational excellence.
-
![alcami fda findings webinar thumb]( "Understanding FDA Calibration Requirements And Best Practices For Reducing Risks")
Understanding FDA Calibration Requirements And Best Practices For Reducing RisksBecome equipped with the tools and strategies needed to strengthen your calibration efforts and better position your organization for success in regulatory audits.
-
How LIMS Supports QC Scaling At Forge Biologics1/21/2026
Modernizing QC workflows with cloud-based systems eliminates paper inefficiencies, reduces errors, and accelerates reporting. Discover how streamlined processes improve compliance and enhance data visibility.
-
CPhI North America 2026: CDMO Partnerships With Mikart4/30/2026
Event-driven blogs highlighting how sponsors can evaluate CDMO partnerships, outsourcing strategies, and formulation development discussions across major 2026 industry conferences.
-
What Pharmacies Often Miss In USP <800> Compliance5/27/2026
Master USP <800> compliance by transitioning from standalone equipment to an integrated system design. Review key protocols for a multi-layered strategy to mitigate cumulative drug risks.
-
Method Development For Forced Degradation Of GLP-1 Agonist3/18/2026
Gain insight into how a systematic approach reveals impurity behavior, strengthens selectivity, and refines chromatographic conditions to build a reliable degradation method for a GLP‑1 agonist.
-
Tips And Tricks Addressing PCR Pain Points3/5/2026
qPCR workflows are vital but prone to common errors. Improve the precision and reliability of your gene expression data by mastering key strategies to overcome frequent experimental pitfalls.
QUALITY CONTROL SOLUTIONS
-
![Milliflex System Feature]( "Rapid System For The Early Detection Of Microbial Contamination")
The Milliflex® Rapid System 2.0 brings together membrane filtration and ATP bioluminescence to detect, image and quantify microcolonies of bacteria, molds and yeasts up to 4 times faster than compendial bioburden or sterility testing methods.
-
![Scientist laboratory GettyImages-542935478]( "FlexUP Technology Renewal Program: Keep Your Lab At The Forefront Of Science")
Choose the ideal mix of services with our FlexUP Technology Renewal Program for continuous operation in your laboratory and across your enterprise.
-
![Gear In Hand]( "High-Risk Package Integrity Testing Systems")
The ongoing R&D of PTI continues to build a powerful set of leading-edge inspection technologies that will bring patented and unique solutions to high risk packaging applications. There is continuous development in the field of creating new test methods for container closure integrity, seal integrity testing and package integrity testing.
-
![GettyImages-1441662840-lab-team-communication-collaboration]( "A Complete Portfolio Of Services Supporting Your QC Micro Laboratory")
In the pharmaceutical industry, microbiological monitoring and testing is highly regulated and complex. Discover how to optimize your QC lab's workflow and ensure compliance with proven services.
-
![vials]( "Container Closure Integrity Of Parenteral Products")
The United States Pharmacopeia USP 1207 guidance has been revised, encouraging the preference to deterministic, quantitative, and reliable non-destructive technologies to comply with quality standards.
